Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ -- Insilico Medicine (HKEX: 3696.HK, "Insilico" or the "Company"), a clinical-stage biotechnology company powered by generative artificial intelligence for drug discovery and development, today announced...
China Literature to Report Full Year 2025 Financial Results on March 17, 2026
- Earnings Conference Call to be Held on Tuesday, March 17, 2026 at 8:00 pm (Hong Kong Time) / 8:00 am (U.S. Eastern Time) HONG KONG, March 3, 2026 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", 0772.HK), a leading...